These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

322 related items for PubMed ID: 19937319

  • 1. LSD but not lisuride disrupts prepulse inhibition in rats by activating the 5-HT(2A) receptor.
    Halberstadt AL, Geyer MA.
    Psychopharmacology (Berl); 2010 Feb; 208(2):179-89. PubMed ID: 19937319
    [Abstract] [Full Text] [Related]

  • 2. Effect of LSD on prepulse inhibition and spontaneous behavior in the rat. A pharmacological analysis and comparison between two rat strains.
    Ouagazzal A, Grottick AJ, Moreau J, Higgins GA.
    Neuropsychopharmacology; 2001 Oct; 25(4):565-75. PubMed ID: 11557170
    [Abstract] [Full Text] [Related]

  • 3. LSD and the phenethylamine hallucinogen DOI are potent partial agonists at 5-HT2A receptors on interneurons in rat piriform cortex.
    Marek GJ, Aghajanian GK.
    J Pharmacol Exp Ther; 1996 Sep; 278(3):1373-82. PubMed ID: 8819525
    [Abstract] [Full Text] [Related]

  • 4. Distinct temporal phases in the behavioral pharmacology of LSD: dopamine D2 receptor-mediated effects in the rat and implications for psychosis.
    Marona-Lewicka D, Thisted RA, Nichols DE.
    Psychopharmacology (Berl); 2005 Jul; 180(3):427-35. PubMed ID: 15723230
    [Abstract] [Full Text] [Related]

  • 5. The hallucinogen d-lysergic diethylamide (LSD) decreases dopamine firing activity through 5-HT1A, D2 and TAAR1 receptors.
    De Gregorio D, Posa L, Ochoa-Sanchez R, McLaughlin R, Maione S, Comai S, Gobbi G.
    Pharmacol Res; 2016 Nov; 113(Pt A):81-91. PubMed ID: 27544651
    [Abstract] [Full Text] [Related]

  • 6. F15063, a compound with D2/D3 antagonist, 5-HT 1A agonist and D4 partial agonist properties. II. Activity in models of positive symptoms of schizophrenia.
    Depoortère R, Bardin L, Auclair AL, Kleven MS, Prinssen E, Colpaert F, Vacher B, Newman-Tancredi A.
    Br J Pharmacol; 2007 May; 151(2):253-65. PubMed ID: 17375086
    [Abstract] [Full Text] [Related]

  • 7. Re-evaluation of lisuride pharmacology: 5-hydroxytryptamine1A receptor-mediated behavioral effects overlap its other properties in rats.
    Marona-Lewicka D, Kurrasch-Orbaugh DM, Selken JR, Cumbay MG, Lisnicchia JG, Nichols DE.
    Psychopharmacology (Berl); 2002 Oct; 164(1):93-107. PubMed ID: 12373423
    [Abstract] [Full Text] [Related]

  • 8. Serotonergic and dopaminergic distinctions in the behavioral pharmacology of (±)-1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI) and lysergic acid diethylamide (LSD).
    Schindler EA, Dave KD, Smolock EM, Aloyo VJ, Harvey JA.
    Pharmacol Biochem Behav; 2012 Mar; 101(1):69-76. PubMed ID: 22197710
    [Abstract] [Full Text] [Related]

  • 9. Hallucinogenic 5-HT2AR agonists LSD and DOI enhance dopamine D2R protomer recognition and signaling of D2-5-HT2A heteroreceptor complexes.
    Borroto-Escuela DO, Romero-Fernandez W, Narvaez M, Oflijan J, Agnati LF, Fuxe K.
    Biochem Biophys Res Commun; 2014 Jan 03; 443(1):278-84. PubMed ID: 24309097
    [Abstract] [Full Text] [Related]

  • 10. Phospholipase C mediates (±)-1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI)-, but not lysergic acid diethylamide (LSD)-elicited head bobs in rabbit medial prefrontal cortex.
    Schindler EA, Harvey JA, Aloyo VJ.
    Brain Res; 2013 Jan 23; 1491():98-108. PubMed ID: 23123701
    [Abstract] [Full Text] [Related]

  • 11. Hallucinogens recruit specific cortical 5-HT(2A) receptor-mediated signaling pathways to affect behavior.
    González-Maeso J, Weisstaub NV, Zhou M, Chan P, Ivic L, Ang R, Lira A, Bradley-Moore M, Ge Y, Zhou Q, Sealfon SC, Gingrich JA.
    Neuron; 2007 Feb 01; 53(3):439-52. PubMed ID: 17270739
    [Abstract] [Full Text] [Related]

  • 12. Complex discriminative stimulus properties of (+)lysergic acid diethylamide (LSD) in C57Bl/6J mice.
    Benneyworth MA, Smith RL, Barrett RJ, Sanders-Bush E.
    Psychopharmacology (Berl); 2005 Jun 01; 179(4):854-62. PubMed ID: 15645221
    [Abstract] [Full Text] [Related]

  • 13. Dopamine agonist-induced hypothermia and disruption of prepulse inhibition: evidence for a role of D3 receptors?
    Varty GB, Higgins GA.
    Behav Pharmacol; 1998 Sep 01; 9(5-6):445-55. PubMed ID: 9832930
    [Abstract] [Full Text] [Related]

  • 14. Actions of novel antipsychotic agents on apomorphine-induced PPI disruption: influence of combined serotonin 5-HT1A receptor activation and dopamine D2 receptor blockade.
    Auclair AL, Kleven MS, Besnard J, Depoortère R, Newman-Tancredi A.
    Neuropsychopharmacology; 2006 Sep 01; 31(9):1900-9. PubMed ID: 16421514
    [Abstract] [Full Text] [Related]

  • 15. Effects of D3/D2 dopamine receptor agonists and antagonists on prepulse inhibition of acoustic startle in the rat.
    Caine SB, Geyer MA, Swerdlow NR.
    Neuropsychopharmacology; 1995 Apr 01; 12(2):139-45. PubMed ID: 7779242
    [Abstract] [Full Text] [Related]

  • 16. Comparative effects of LSD and lisuride: clues to specific hallucinogenic drug actions.
    White FJ.
    Pharmacol Biochem Behav; 1986 Feb 01; 24(2):365-79. PubMed ID: 3952127
    [Abstract] [Full Text] [Related]

  • 17. Lysergic acid diethylamide-induced Fos expression in rat brain: role of serotonin-2A receptors.
    Gresch PJ, Strickland LV, Sanders-Bush E.
    Neuroscience; 2002 Feb 01; 114(3):707-13. PubMed ID: 12220572
    [Abstract] [Full Text] [Related]

  • 18. Agonist activity of LSD and lisuride at cloned 5HT2A and 5HT2C receptors.
    Egan CT, Herrick-Davis K, Miller K, Glennon RA, Teitler M.
    Psychopharmacology (Berl); 1998 Apr 01; 136(4):409-14. PubMed ID: 9600588
    [Abstract] [Full Text] [Related]

  • 19. F15063, a compound with D2/D3 antagonist, 5-HT 1A agonist and D4 partial agonist properties. III. Activity in models of cognition and negative symptoms.
    Depoortère R, Auclair AL, Bardin L, Bruins Slot L, Kleven MS, Colpaert F, Vacher B, Newman-Tancredi A.
    Br J Pharmacol; 2007 May 01; 151(2):266-77. PubMed ID: 17375085
    [Abstract] [Full Text] [Related]

  • 20. Pharmacological and biotransformation studies of 1-acyl-substituted derivatives of d-lysergic acid diethylamide (LSD).
    Halberstadt AL, Chatha M, Klein AK, McCorvy JD, Meyer MR, Wagmann L, Stratford A, Brandt SD.
    Neuropharmacology; 2020 Aug 01; 172():107856. PubMed ID: 31756337
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.